United Therapeutics reported $116M in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Amarin AMRN:US $ -69.96M 38.39M
Baxter International BAX:US $ 252M 181M
Bayer BAYN:GR € 3291M 2130M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Biogen BIIB:US $ 1058M 754.2M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Insmed INSM:US $ -95645000 1.02M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Johnson & Johnson JNJ:US $ 4814M 335M
Lexicon Pharmaceuticals LXRX:US $ -24.59M 1.11M
Moderna Inc MRNA:US 2.2B 1.46B
Pfizer PFE:US $ 9905M 2042M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Teva Pharmaceutical TEVA:IT -233000000 722M
United Therapeutics UTHR:US $ 116M 123.9M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M